Cyteir Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cyteir Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2023.
  • Cyteir Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 36M shares, a 1.99% increase year-over-year.
  • Cyteir Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 35.3M shares, a 80.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 36M +701K +1.99% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 35.7M +464K +1.32% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 35.6M +347K +0.98% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 35.3M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 35.3M +266K +0.76% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 35.3M +32.9M +1409% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 35.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 35.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 2.34M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.